BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 24
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (9697)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF611
HTML8618
Figures (1-1)243
Tables (1-3)225
 Sum=9697
Jun 28, 2008 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Hov JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 2008; 14(24): 3781-3791 [PMID: 18609700 DOI: 10.3748/wjg.14.3781]
URL: https://www.wjgnet.com/1007-9327/full/v14/i24/3781.htm
Number Citing Articles
1
Manoj Thapa, Dana Tedesco, Sanjeev Gumber, Elizabeth J. Elrod, Jin-Hwan Han, William H. Kitchens, Joseph F. Magliocca, Andrew B. Adams, Arash Grakoui. Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease. The Journal of Immunology 2020; 204(12): 3117 doi: 10.4049/jimmunol.1900391
2
Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, Matteo Gastaldi, Serena Bugatti, Mario Rotondi, Paola Ilaria Bianchi, Antonella Gentile, Luca Chiovato, Carlomaurizio Montecucco, Gino Roberto Corazza, Antonio Di Sabatino. Seronegative autoimmune diseases: A challenging diagnosis. Autoimmunity Reviews 2022; 21(9): 103143 doi: 10.1016/j.autrev.2022.103143
3
D. Robert Dufour. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 2012; : 1637 doi: 10.1016/B978-1-4160-6164-9.00050-0
4
Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin. Mechanisms of tissue injury in autoimmune liver diseases. Seminars in Immunopathology 2014; 36(5): 553 doi: 10.1007/s00281-014-0439-3
5
David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos, Maria Papp. Serological biomarkers for management of primary sclerosing cholangitis. World Journal of Gastroenterology 2022; 28(21): 2291-2301 doi: 10.3748/wjg.v28.i21.2291
6
José Franco. Liver Disorders. 2017; : 289 doi: 10.1007/978-3-319-30103-7_17
7
Pan Luo, Lin Liu, Weikun Hou, Ke Xu, Peng Xu, Nadeem Sheikh. Gene Set Enrichment Analysis Detected Immune Cell-Related Pathways Associated with Primary Sclerosing Cholangitis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2371347
8
Matteo Bramuzzo, Stefano Martelossi, Giuliano Torre, Sabrina Cardile, Serena Arrigo, Silvia Vignola, Federica Ferrari, Giovanna Zuin, Maria Teresa Illiceto, Marco Gasparetto, Salvatore Pellegrino, Claudio Romano, Giuseppe Maggiore, Marcella Montico, Marina Aloi. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(2): 259 doi: 10.1097/MPG.0000000000001078
9
Alpha Boubacar Conte, Fatoumata Coulibaly, Sofia Jayi, Fatima Zohra Fdili Alaoui, Hikmat Chaara, Moulay Abdelilah Melhouf. Primary sclerosing cholangitis revealed by pregnancy. Obstetrics & Gynecology International Journal 2023; 14(2): 62 doi: 10.15406/ogij.2023.14.00695
10
Ida Schregel, Silja Steinmann, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 2). Gastroenterologie up2date 2022; 18(03): 245 doi: 10.1055/a-1922-9264
11
Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Journal of Hepatology 2011; 54(2): 374 doi: 10.1016/j.jhep.2010.09.002
12
A. Schreiber, B. Rudolph, A. Kahl, R. Kettritz. Akutes Nierenversagen bei einem lebertransplantierten Patienten. Der Nephrologe 2015; 10(5): 416 doi: 10.1007/s11560-014-0932-7
13
Brian K. Chung, Gideon M. Hirschfield. Immunogenetics in primary sclerosing cholangitis. Current Opinion in Gastroenterology 2017; 33(2): 93 doi: 10.1097/MOG.0000000000000336
14
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 2017; 67(6): 1298 doi: 10.1016/j.jhep.2017.07.022
15
Dominik Roth, Miriam M Düll, Ludwig J Horst, Aylin Lindemann, Xenia Malzer, Kristina Koop, Sebastian Zundler, Marcel Vetter, André Jefremow, Raja Atreya, Carol Geppert, Sören Weidemann, Maximilian J Waldner, Peter Dietrich, Claudia Günther, Luis E Munoz, Martin Herrmann, Alexander Scheffold, Markus F Neurath, Jürgen Siebler, Christoph Schramm, Andreas E Kremer, Moritz Leppkes. Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2024;  doi: 10.1093/ecco-jcc/jjae131
16
Shou-Pei Liu, Zhen-Hua Bian, Zhi-Bin Zhao, Jinjun Wang, Weici Zhang, Patrick S.C. Leung, Liang Li, Zhe-Xiong Lian. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 2020; 58(2): 252 doi: 10.1007/s12016-020-08778-6
17
Elisabeth M.G. de Vries, Ulrich Beuers, Cyriel Y. Ponsioen. Biomarkers for disease progression of primary sclerosing cholangitis. Current Opinion in Gastroenterology 2015; 31(3): 239 doi: 10.1097/MOG.0000000000000163
18
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno, Hajime Takikawa. Clinical guidelines for primary sclerosing cholangitis 2017. Journal of Gastroenterology 2018; 53(9): 1006 doi: 10.1007/s00535-018-1484-9
19
Takuma Misawa, Jeffrey A. SoRelle, Jin Huk Choi, Tao Yue, Kuan-wen Wang, William McAlpine, Jianhui Wang, Aijie Liu, Koichi Tabeta, Emre E. Turer, Bret Evers, Evan Nair-Gill, Subhajit Poddar, Lijing Su, Feiya Ou, Liyang Yu, Jamie Russell, Sara Ludwig, Xiaoming Zhan, Sara Hildebrand, Xiaohong Li, Miao Tang, Anne R. Murray, Eva Marie Y. Moresco, Bruce Beutler. Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiation. Science Immunology 2020; 5(43) doi: 10.1126/sciimmunol.aaz0085
20
Silja Steinmann, Ida Schregel, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 1). Gastroenterologie up2date 2022; 18(03): 225 doi: 10.1055/a-1364-8489
21
James P. Stevens, Nitika A. Gupta. Recent Insights into Pediatric Primary Sclerosing Cholangitis. Clinics in Liver Disease 2022; 26(3): 489 doi: 10.1016/j.cld.2022.03.009
22
William Balistreri, Simon Lam. Liver Disease in Children. 2021; : 333 doi: 10.1017/9781108918978.021
23
Teresa Da Cunha, Haleh Vaziri, George Y. Wu. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review. Journal of Clinical and Translational Hepatology 2022; 10(3): 531 doi: 10.14218/JCTH.2021.00344
24
Priscila Menezes Ferri, Ana Cristina Simões e Silva, Soraya Luiza Campos Silva, Diego Junior Queiroga de Aquino, Eleonora Druve Tavares Fagundes, Débora Marques de Miranda, Alexandre Rodrigues Ferreira. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/3905240
25
A. I. Parfenov, A. V. Kagramanova, O. V. Knyazev. Systemic manifestations of inflammatory bowel diseases. Terapevticheskii arkhiv 2020; 92(2): 4 doi: 10.26442/00403660.2020.02.000535
26
Nina Barner-Rasmussen, Nelli Sjöblom, Johanna Arola, Sonja Boyd, Hannu Kautiainen, Martti Färkkilä. The role of serology, liver function tests and imaging in screening of primary sclerosing cholangitis: the HelPSCreen score. Scandinavian Journal of Gastroenterology 2023; 58(12): 1491 doi: 10.1080/00365521.2023.2233038
27
U. Spengler. Differenzialdiagnose Ikterus. Der Gastroenterologe 2010; 5(4): 363 doi: 10.1007/s11377-009-0390-3
28
Rosanna Villani, Gaetano Serviddio, Carlo Avolio, Tommaso Cassano, Emanuele D’Amico. Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives. Clinical and Experimental Medicine 2023; 23(7): 3321 doi: 10.1007/s10238-023-01128-8
29
Paola De Angelis, Renato Tambucci, Erminia Romeo, Francesca Rea, Claudia Caloisi, Tamara Caldaro, Giovanni Federici di Abriola, Francesca Foschia, Filippo Torroni, L. Monti, Luigi Dall'Oglio. Does an isolated benign choledochal stricture hide a PSC?. Journal of Pediatric Surgery 2013; 48(5): 1006 doi: 10.1016/j.jpedsurg.2013.02.020
30
Vitantonio GUGLIELMI, Pietro GIORGIO, Vito GUERRA, Anna SONNANTE, Massimo TUTINO, Rossella DONGHIA, Antonio PISANI. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis. Minerva Medica 2022; 113(3) doi: 10.23736/S0026-4806.20.06604-5
31
Lena Berglin, Niklas K. Björkström, Annika Bergquist. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells. Scandinavian Journal of Gastroenterology 2013; 48(6): 719 doi: 10.3109/00365521.2013.786131
32
T. Liwinski, C. Schramm. Primär sklerosierende Cholangitis. Der Internist 2018; 59(6): 551 doi: 10.1007/s00108-018-0428-z
33
Johannes R. Hov, Kirsten M. Boberg, Eli Taraldsrud, Mette Vesterhus, Maria Boyadzhieva, Inger Camilla Solberg, Erik Schrumpf, Morten H. Vatn, Benedicte A. Lie, Øyvind Molberg, Tom H. Karlsen. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Liver International 2017; 37(3): 458 doi: 10.1111/liv.13238
34
Maria C. SORRENTINO, Teresa CARBONE, Luigi CINQUANTA, Maria G. ALESSIO, Maria INFANTINO, Gaia DELEONARDI, Maria T. TREVISAN, Brunetta PORCELLI, Lucia TERZUOLI, Stefan PLATZGUMMER, Ignazio BRUSCA, Antonio ANTICO, Marilina TAMPOIA, Giampaola PESCE, Danilo VILLALTA, Nicola BIZZARO. Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegato. La Rivista Italiana della Medicina di Laboratorio 2024; 20(1) doi: 10.23736/S1825-859X.24.00226-3
35
John M. Vierling. Primary Sclerosing Cholangitis. 2017; : 111 doi: 10.1007/978-3-319-40908-5_9
36
Gary L. Norman, Nicola Bizzaro, Danilo Villalta, Diego Vergani, Giorgina Mieli-Vergani, Gideon M. Hirschfield, Michael Mahler. Precision Medicine and Artificial Intelligence. 2021; : 135 doi: 10.1016/B978-0-12-820239-5.00012-7
37
Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, Michele Biagioli, Eleonora Distrutti. Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments. Cells 2024; 13(19): 1650 doi: 10.3390/cells13191650
38
Stefano Fiorucci, Silvia Marchianò, Ginevra Urbani, Cristina Di Giorgio, Eleonora Distrutti, Angela Zampella, Michele Biagioli. Immunology of bile acids regulated receptors. Progress in Lipid Research 2024; 95: 101291 doi: 10.1016/j.plipres.2024.101291
39
Yash R Shah, Natalia Nombera-Aznaran, David Guevara-Lazo, Ernesto Calderon-Martinez, Angad Tiwari, SriLakshmiDevi Kanumilli, Purva Shah, Bhanu Siva Mohan Pinnam, Hassam Ali, Dushyant Singh Dahiya. Liver transplant in primary sclerosing cholangitis: Current trends and future directions. World Journal of Hepatology 2023; 15(8): 939-953 doi: 10.4254/wjh.v15.i8.939
40
Rosebella A. Iseme, Mark McEvoy, Brian Kelly, Linda Agnew, Frederick R. Walker, Michael Boyle, John Attia. A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune Disease. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/9407971
41
Claudia O. Zein. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2013; 17(2): 211 doi: 10.1016/j.cld.2012.11.003
42
Sergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, Dimitrios P. Bogdanos, Elena Csernok, Jan Damoiseaux, Marc Ferrante, Luis Felipe Flores-Suárez, Marvin J. Fritzler, Pietro Invernizzi, David Jayne, J. Charles Jennette, Mark A. Little, Stephen P. McAdoo, Pavel Novikov, Charles D. Pusey, Antonella Radice, Alan D. Salama, Judith A. Savige, Mårten Segelmark, Yehuda Shoenfeld, Renato A. Sinico, Maria-José Sousa, Ulrich Specks, Benjamin Terrier, Athanasios G. Tzioufas, Severine Vermeire, Ming-Hui Zhao, Xavier Bossuyt. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmunity Reviews 2020; 19(9): 102618 doi: 10.1016/j.autrev.2020.102618
43
Kirsten Muri Boberg. Autoimmune Hepatitis. 2012; : 217 doi: 10.1007/978-1-60761-569-9_12
44
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clinical Reviews in Allergy & Immunology 2021; 63(2): 124 doi: 10.1007/s12016-021-08888-9
45
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
46
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024; 28(1): 129 doi: 10.1016/j.cld.2023.07.005
47
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 2009; 51(2): 237 doi: 10.1016/j.jhep.2009.04.009
48
Sarajo Kumar Mohanta, Changjun Yin, Li Peng, Prasad Srikakulapu, Vineela Bontha, Desheng Hu, Falk Weih, Christian Weber, Norbert Gerdes, Andreas J.R. Habenicht. Artery Tertiary Lymphoid Organs Contribute to Innate and Adaptive Immune Responses in Advanced Mouse Atherosclerosis. Circulation Research 2014; 114(11): 1772 doi: 10.1161/CIRCRESAHA.114.301137
49
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitis. Pathology International 2016; 66(7): 404 doi: 10.1111/pin.12427
50
Haiyan Zhang, Patrick S.C. Leung, M. Eric Gershwin, Xiong Ma. How the biliary tree maintains immune tolerance?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1367 doi: 10.1016/j.bbadis.2017.08.019
51
Brian K. Chung, Bardia T. Guevel, Gary M. Reynolds, D.B.R.K. Gupta Udatha, Eva Kristine Klemsdal Henriksen, Zania Stamataki, Gideon M. Hirschfield, Tom Hemming Karlsen, Evaggelia Liaskou. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. Journal of Autoimmunity 2017; 77: 45 doi: 10.1016/j.jaut.2016.10.003
52
K. Wiencke, K.M. Boberg. Current consensus on the management of primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2011; 35(12): 786 doi: 10.1016/j.clinre.2011.04.007
53
Nora Cazzagon, Olivier Chazouillères. Diseases of the Liver and Biliary Tree. 2021; : 169 doi: 10.1007/978-3-030-65908-0_11
54
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
55
Caterina Maria Gambino, Luisa Agnello, Vincenza Calvaruso, Rosaria Vincenza Giglio, Luigi Capodicasa, Concetta Scazzone, Giuseppina Candore, Fabio Del Ben, Vito Di Marco, Marcello Ciaccio. Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience. Clinica Chimica Acta 2025; 566: 120037 doi: 10.1016/j.cca.2024.120037
56
Sang-Heum Park, Hoo Rim Song, Sung Won Lee, Tae Hoon Lee. Wouldn't Human Understanding be Necessary to Treat Patients with Pancreaticobiliary Disease More Effectively?. The Korean Journal of Pancreas and Biliary Tract 2018; 23(3): 89 doi: 10.15279/kpba.2018.23.3.89
57
Ziwen Pan, Weijie Zhang. Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01941-1
58
Muneji Yasuda, Masahiro Shiokawa, Takeshi Kuwada, Yoshihiro Nishikawa, Risa Nakanishi, Ikuhisa Takimoto, Koki Chikugo, Masataka Yokode, Yuya Muramoto, Shimpei Matsumoto, Takeharu Nakamura, Sakiko Ota, Tomoaki Matsumori, Keiko Kuroda, Takahisa Hachiya, Hajime Yamazaki, Norimitsu Uza, Yuzo Kodama, Tsutomu Chiba, Toshio Fujisawa, Atsumasa Komori, Masanori Abe, Izumi Yamaguchi, Fumihiko Matsuda, Hiroyuki Isayama, Atsushi Tanaka, Hiroshi Seno. Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study. Journal of Gastroenterology 2024;  doi: 10.1007/s00535-024-02169-w
59
Beate Preuß, Amelie Frank, Birgit Terjung, Ulrich Spengler, Christoph Berg, Reinhild Klein. Autoantibodies to beta tubulin in autoimmune liver diseases—Relation to pANCA and clinical relevance. Clinical and Experimental Immunology 2024; 216(2): 146 doi: 10.1093/cei/uxad114
60
Claudiu Marinel Ionele, Adina Turcu-Stiolica, Mihaela Simona Subtirelu, Bogdan Silviu Ungureanu, George Ovidiu Cioroianu, Ion Rogoveanu. A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Medicine 2022; 11(13): 3807 doi: 10.3390/jcm11133807
61
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 2023; 20(3): 135 doi: 10.1038/s41575-022-00690-y
62
Hyun Jin Cha, Jimin Hwang, Lucy Eunju Lee, Younhee Park, Jason Jungsik Song, Gianfranco D. Alpini. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease. PLOS ONE 2021; 16(1): e0244950 doi: 10.1371/journal.pone.0244950
63
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity 2018; 95: 144 doi: 10.1016/j.jaut.2018.10.004
64
Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke, Tom H. Karlsen. Genetics in primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2012; 36(4): 325 doi: 10.1016/j.clinre.2012.02.003
65
Dong Xi, Henry Lin, Amit A. Shah. Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodies. Clinical Liver Disease 2022; 20(4): 111 doi: 10.1002/cld.1227
66
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1): 39 doi: 10.21508/1027-4065-2021-66-1-39-46
67
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4): 965 doi: 10.1097/HEP.0000000000000506
68
Brian K. Chung, Eva Kristine Klemsdal Henriksen, Kristin Kaasen Jørgensen, Tom H. Karlsen, Gideon M. Hirschfield, Evaggelia Liaskou. Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease. Hepatology Communications 2018; 2(8): 960 doi: 10.1002/hep4.1200
69
Hyeok Choi, Yong-Beom Park, Jaewoo Song, Sang-Won Lee. Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis. Zeitschrift für Rheumatologie 2022; 81(8): 705 doi: 10.1007/s00393-021-00998-1
70
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
71
Simona Marzorati, Pietro Invernizzi, Ana Lleo. Making Sense of Autoantibodies in Cholestatic Liver Diseases. Clinics in Liver Disease 2016; 20(1): 33 doi: 10.1016/j.cld.2015.08.003
72
Albert Parés. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento. Gastroenterología y Hepatología 2011; 34(1): 41 doi: 10.1016/j.gastrohep.2010.02.006
73
Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, Saša Grgov. Clinical connection between rheumatoid arthritis and liver damage. Rheumatology International 2018; 38(5): 715 doi: 10.1007/s00296-018-4021-5
74
Tom H. Karlsen, Kirsten Muri Boberg, Erik Schrumpf. Zakim and Boyer's Hepatology. 2012; : 754 doi: 10.1016/B978-1-4377-0881-3.00042-5
75
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77(2): 659 doi: 10.1002/hep.32771
76
Tom Hemming Karlsen, Gideon M. Hirschfield. Primary Sclerosing Cholangitis. 2017; : 99 doi: 10.1007/978-3-319-40908-5_8
77
Hanh D. Vo, Jiliu Xu, Simon S. Rabinowitz, Stanley E. Fisher, Steven M. Schwarz. The Liver in Pediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(3): 288 doi: 10.1097/MPG.0000000000000444
78
Alexander Zipprich. Rheumatologie und Hepatologie: Diagnostik und Therapie von autoimmunen Lebererkrankungen. Aktuelle Rheumatologie 2021; 46(05): 457 doi: 10.1055/a-0885-9314
79
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Liver Immunology. 2020; : 49 doi: 10.1007/978-3-030-51709-0_4
80
Michal Prokopič, Ulrich Beuers. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Hepatology International 2021; 15(1): 6 doi: 10.1007/s12072-020-10118-x
81
Ban‐Hock Toh. Diagnostic autoantibodies for autoimmune liver diseases. Clinical & Translational Immunology 2017; 6(5) doi: 10.1038/cti.2017.14
82
Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida, Gino Roberto Corazza. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Digestive and Liver Disease 2017; 49(9): 947 doi: 10.1016/j.dld.2017.06.010
83
Verghese George, Varaha Sairam Tammisetti, Venkateswar Rao Surabhi, Alampady K. Shanbhogue. Chronic Fibrosing Conditions in Abdominal Imaging. RadioGraphics 2013; 33(4): 1053 doi: 10.1148/rg.334125081
84
Henrike Lenzen, Tobias J. Weismüller, Ahmed A. Negm, Jenny Wlecke, Stephanie Loges, Christian P. Strassburg, Michael P. Manns, Tim O. Lankisch. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 2013; 48(10): 1205 doi: 10.3109/00365521.2013.825313
85
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler. Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018). Terapevticheskii arkhiv 2019; 91(2): 9 doi: 10.26442/00403660.2019.02.000075
86
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model. Liver International 2019; 39(12): 2330 doi: 10.1111/liv.14183
87
Kazuhito Kawata, Yoshimasa Kobayashi, M. Eric Gershwin, Christopher L. Bowlus. The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clinical Reviews in Allergy & Immunology 2012; 43(3): 230 doi: 10.1007/s12016-012-8324-0
88
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases. 2014; : 925 doi: 10.1016/B978-0-12-384929-8.00063-0
89
Sebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, Laila Widmann, Tobias Korf, Maike Anna Michaels, Karl-Heinz Weiss, Evaggelia Liaskou, Mette Vesterhus, Tom Hemming Karlsen, Swantje Mindorf, Peter Schemmer, Florian Bär, Bianca Teegen, Torsten Schröder, Marc Ehlers, Christoph Matthias Hammers, Lars Komorowski, Hendrik Lehnert, Klaus Fellermann, Stefanie Derer, Johannes Roksund Hov, Christian Sina. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 2017; 66(1): 137 doi: 10.1136/gutjnl-2016-311739
90
Claudia O. Zein, Keith D. Lindor. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Current Gastroenterology Reports 2010; 12(1): 13 doi: 10.1007/s11894-009-0079-2
91
Roopa Hebbandi Nanjundappa, Kun Shao, Prasanna Krishnamurthy, M. Eric Gershwin, Patrick S.C. Leung, Channakeshava Sokke Umeshappa. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications. Autoimmunity Reviews 2024; 23(2): 103485 doi: 10.1016/j.autrev.2023.103485
92
Joyce J B C van Beers, Ger H Koek, Jan G M C Damoiseaux. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. The Journal of Applied Laboratory Medicine 2022; 7(1): 259 doi: 10.1093/jalm/jfab099
93
Guilherme Grossi Lopes Cançado, Gideon M. Hirschfield. Management of primary sclerosing cholangitis: Current state-of-the-art. Hepatology Communications 2024; 8(12) doi: 10.1097/HC9.0000000000000590
94
José Franco. Pancreas and Biliary Disease. 2016; : 321 doi: 10.1007/978-3-319-28089-9_14
95
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
96
Tamsin Cargill, Emma L. Culver. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661196
97
Marcial Sebode, Lisa Schulz, Ansgar Lohse. “Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. International Journal of Molecular Sciences 2017; 18(9): 1954 doi: 10.3390/ijms18091954
98
Janet Martin, Eleonora Petryayeva, Waliul I Khan. Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals. The Journal of Applied Laboratory Medicine 2022; 7(1): 114 doi: 10.1093/jalm/jfab131
99
Xiaojun Jiang, Tom H. Karlsen. Genetics of primary sclerosing cholangitis and pathophysiological implications. Nature Reviews Gastroenterology & Hepatology 2017; 14(5): 279 doi: 10.1038/nrgastro.2016.154
100
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani. Autoimmune Liver Disease. 2020; : 65 doi: 10.1002/9781119532637.ch4
101
Kelly Hudspeth, Elena Pontarini, Paolo Tentorio, Matteo Cimino, Matteo Donadon, Guido Torzilli, Enrico Lugli, Silvia Della Bella, M. Eric Gershwin, Domenico Mavilio. The role of natural killer cells in autoimmune liver disease: A comprehensive review. Journal of Autoimmunity 2013; 46: 55 doi: 10.1016/j.jaut.2013.07.003
102
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Experimental & Molecular Medicine 2023; 55(7): 1380 doi: 10.1038/s12276-023-01042-9
103
Christopher L. Bowlus. Liver Immunology. 2014; : 45 doi: 10.1007/978-3-319-02096-9_4
104
Shikib Mostamand, Shauna Schroeder, Jacqueline Schenkein, Tamir Miloh. Infliximab‐Associated Immunomediated Hepatitis in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1): 94 doi: 10.1097/MPG.0000000000001137
105
Abin Chandrakumar, Rachael Loeppky, Mark Deneau, Wael El-Matary. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. The Journal of Pediatrics 2019; 215: 144 doi: 10.1016/j.jpeds.2019.07.065
106
Andrzej Chruscinski, Stephen Juvet, Sajad Moshkelgosha, Eberhard Renner, Leslie Lilly, Nazia Selzner, Christopher Bredeson, David Grant, Oyedele Adeyi, Sandra Fischer, Anthony J. Demetris, Jianhua Zhang, Maor Epstein, Meaghan Macarthur, Anne Marie Clement, Korosh Khalili, David Allan, Sultan Altouri, Isabelle Bence-Bruckler, Mark Cattral, Jill Fulcher, Zita Galvin, Anand Ghanekar, Paul Greig, Lothar Huebsch, Atul Humar, Andrea Kew, Natasha Kekre, Tae Kyoung Kim, Sheryl McDiarmid, Lisa Martin, Ian McGilvray, Mitchell Sabloff, Gonzalo Sapisochin, Markus Selzner, Robert Smith, Kathryn Tinckam, Tae Joon Yi, Gary Levy, Harold Atkins. Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study. Transplantation 2022; 106(3): 562 doi: 10.1097/TP.0000000000003829
107
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Clinical significance of autoantibodies in autoimmune hepatitis. Journal of Autoimmunity 2013; 46: 17 doi: 10.1016/j.jaut.2013.08.001
108
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 2015; 50(6): 781 doi: 10.3109/00365521.2015.1028996
109
Channakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, Kun Shao, Roopa Hebbandi Nanjundappa, Jun Yamanouchi, Albert Parés, Pau Serra, Yang Yang, Pere Santamaria. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09893-5
110
C. Buffet. Cholangites sclérosantes. EMC - Hépatologie 2011; 6(1): 1 doi: 10.1016/S1155-1976(11)50375-4
111
Johannes R Hov, Øyvind Molberg, Tom H Karlsen. Tubulin beta 5 is not the target of antineutrophil antibodies in primary sclerosing cholangitis. Clinical and Experimental Immunology 2024; 218(1): 75 doi: 10.1093/cei/uxae053
112
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approach. European Journal of Internal Medicine 2018; 48: 35 doi: 10.1016/j.ejim.2017.10.006
113
Piotr Milkiewicz, Marcin Krawczyk, Ewa Wunsch, Cyriel Ponsioen, Gideon M. Hirschfield, Stefan G. Hubscher. Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management. Hepatology Communications 2020; 4(3): 399 doi: 10.1002/hep4.1467
114
Nathalie Pena Polanco, Claudia Cottone, Kalyan Ram Bhamidimarri. PSC and Overlap Syndromes. Current Hepatology Reports 2020; 19(2): 106 doi: 10.1007/s11901-020-00518-w
115
Jason B. Samarasena, Ke-Qin Hu. Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders. Clinics in Liver Disease 2011; 15(1): 89 doi: 10.1016/j.cld.2010.09.003
116
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012; 36(6): 517 doi: 10.1111/j.1365-2036.2012.05223.x
117
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider, Gregory J. Gores. Diagnosis and Management of Primary Sclerosing Cholangitis. Hepatology 2010; 51(2): 660 doi: 10.1002/hep.23294
118
Samar H. Ibrahim, Keith D. Lindor. Current Management of Primary Sclerosing Cholangitis in Pediatric Patients. Pediatric Drugs 2011; 13(2): 87 doi: 10.2165/11586500-000000000-00000
119
Elisabeth Krones, Ivo Graziadei, Michael Trauner, Peter Fickert. Evolving concepts in primary sclerosing cholangitis. Liver International 2012; 32(3): 352 doi: 10.1111/j.1478-3231.2011.02607.x
120
Nora Cazzagon, Samantha Sarcognato, Elisa Catanzaro, Emanuela Bonaiuto, Matteo Peviani, Francesco Pezzato, Raffaella Motta. Primary Sclerosing Cholangitis: Diagnostic Criteria. Tomography 2024; 10(1): 47 doi: 10.3390/tomography10010005
121
Tom H. Karlsen, Erik Schrumpf, Kirsten M. Boberg. Update on primary sclerosing cholangitis. Digestive and Liver Disease 2010; 42(6): 390 doi: 10.1016/j.dld.2010.01.011
122
Krisztina Hagymási, Zsolt Tulassay. Review of overlap syndromes of autoimmune liver diseases. Difficulties in the diagnosis and treatment. Orvosi Hetilap 2013; 154(24): 923 doi: 10.1556/OH.2013.29640
123
Klaus Felix, Oliver Hauck, Martina Schnölzer, Tore Kempf, Uwe Warnken, Kathrin Schneider, Frank Bergmann, Stefan Fritz, Jens Werner. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma. Pancreas 2016; 45(9): 1309 doi: 10.1097/MPA.0000000000000647
124
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System. 2018; : 341 doi: 10.1002/9781119237662.ch18
125
Christopher L. Bowlus. Liver Immunology. 2020; : 395 doi: 10.1007/978-3-030-51709-0_25
126
Naomi Richardson, Sky T. H. Ng, David C. Wraith. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01586
127
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3): 761 doi: 10.1016/j.jhep.2022.05.011
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345